KLHL14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.37279999981688E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.36859999952688E-07 |
Normal-vs-Stage2 |
2.17650000000624E-06 |
Normal-vs-Stage3 |
1.36490000413048E-08 |
Normal-vs-Stage4 |
4.85709999997752E-06 |
Stage1-vs-Stage2 |
6.913400E-01 |
Stage1-vs-Stage3 |
4.483700E-03 |
Stage1-vs-Stage4 |
9.160600E-01 |
Stage2-vs-Stage3 |
3.106000E-01 |
Stage2-vs-Stage4 |
6.959000E-01 |
Stage3-vs-Stage4 |
3.143700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.35070000020876E-07 |
Normal-vs-AfricanAmerican |
4.68900000050176E-07 |
Normal-vs-Asian |
7.32909954948013E-10 |
Caucasian-vs-AfricanAmerican |
6.717000E-01 |
Caucasian-vs-Asian |
6.952904918478E-11 |
AfricanAmerican-vs-Asian |
6.42270000517087E-08 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.47199999966929E-07 |
Normal-vs-Female |
1.90069999961295E-07 |
Male-vs-Female |
2.016600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.75329999980201E-07 |
Normal-vs-Extreme_Weight |
4.95620000040553E-07 |
Normal-vs-Obese |
5.2703999997572E-07 |
Normal-vs-Extreme_Obese |
1.55469999985058E-07 |
Normal_Weight-vs-Extreme_Weight |
9.233000E-01 |
Normal_Weight-vs-Obese |
9.663800E-01 |
Normal_Weight-vs-Extreme_Obese |
2.980400E-01 |
Extreme_Weight-vs-Obese |
9.471600E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.880840E-01 |
Obese-vs-Extreme_Obese |
2.818000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.35219999980652E-07 |
Normal-vs-Age(41-60Yrs) |
1.0663999999716E-06 |
Normal-vs-Age(61-80Yrs) |
1.05859999988134E-07 |
Normal-vs-Age(81-100Yrs) |
9.77070000462987E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.658000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.975400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.835800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.021220E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.507500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.662600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
6.57369999990109E-07 |
Normal-VS-Type2 PRCC |
3.2821000028882E-08 |
Normal-VS-KIRP CIMP |
8.37300000444685E-08 |
Normal-VS-Unclassified PRCC |
3.29289999712046E-08 |
Type1 PRCC-VS-Type2 PRCC |
4.541000E-03 |
Type1 PRCC-VS-KIRP CIMP |
7.798200E-02 |
Type1 PRCC-VS-Unclassified PRCC |
1.527950E-02 |
Type2 PRCC-VS-KIRP CIMP |
8.764600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
9.974400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
8.646800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.04039999948569E-08 |
Normal-vs-N1 |
8.16180000251521E-08 |
Normal-vs-N2 |
1.847160E-01 |
N0-vs-N1 |
1.318830E-01 |
N0-vs-N2 |
4.401000E-04 |
N1-vs-N2 |
9.065000E-03 |
|
|